fbpx

X

Pioneering New Frontiers: Ovid Therapeutics’ Journey to Revolutionize Epilepsy and CNS Treatment

Pioneering New Frontiers: Ovid Therapeutics’ Journey to Revolutionize Epilepsy and CNS Treatment

In the US, epilepsy affects over 3 million adults and 470,000 children. Characterized by unpredictable seizures, epilepsy imposes significant burdens, not only due to the physical risks associated with seizures but also through profound social, psychological and economic impacts.